January 23, 2018
Rose
Bio-Optronics — a producer of software and services focused on clinical research, automated scheduling, and patient safety — has announced $30 million in funding from growth equity firm Mainsail Partners.
from MobiHealthNews http://ift.tt/2E3bkVW
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment